AR006598A1 - "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" - Google Patents

"composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"

Info

Publication number
AR006598A1
AR006598A1 ARP970101437A ARP970101437A AR006598A1 AR 006598 A1 AR006598 A1 AR 006598A1 AR P970101437 A ARP970101437 A AR P970101437A AR P970101437 A ARP970101437 A AR P970101437A AR 006598 A1 AR006598 A1 AR 006598A1
Authority
AR
Argentina
Prior art keywords
fungous
medicines
compositions
procedure
manufacture
Prior art date
Application number
ARP970101437A
Other languages
English (en)
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR006598(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9611006.9A external-priority patent/GB9611006D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of AR006598A1 publication Critical patent/AR006598A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Es una composición farmacéutica para administración intravenosa a un paciente, que comprende: a) una cantidad farmacéuticamente efectiva de uncompuesto de fórmula (I) y las sales farmacéuticamente aceptables del mismo; b)una cantidadfarmac éuticamente aceptable de un excipiente, tal como unagente de volumen efectivo para formar una toma liofilizada; y c) una cantidad farmacéuticamente aceptable de tampón acetato, efectivo para proveerun pH entre alrededor de 4 y 7.
ARP970101437A 1996-04-19 1997-04-10 "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" AR006598A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1563896P 1996-04-19 1996-04-19
GBGB9611006.9A GB9611006D0 (en) 1996-05-24 1996-05-24 Antifungal compositions

Publications (1)

Publication Number Publication Date
AR006598A1 true AR006598A1 (es) 1999-09-08

Family

ID=26309400

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101437A AR006598A1 (es) 1996-04-19 1997-04-10 "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"

Country Status (36)

Country Link
EP (1) EP0904098B1 (es)
JP (1) JP3258672B2 (es)
CN (1) CN1132624C (es)
AR (1) AR006598A1 (es)
AT (1) ATE241999T1 (es)
AU (1) AU706250B2 (es)
BG (1) BG64272B1 (es)
BR (2) BRPI9708706C8 (es)
CA (1) CA2251928C (es)
CO (1) CO4940486A1 (es)
CY (1) CY2374B1 (es)
CZ (1) CZ289361B6 (es)
DE (1) DE69722615T2 (es)
DK (1) DK0904098T3 (es)
DZ (1) DZ2205A1 (es)
EA (1) EA001386B1 (es)
EE (1) EE04265B1 (es)
ES (1) ES2198569T3 (es)
HK (1) HK1020873A1 (es)
HR (1) HRP970201B1 (es)
HU (1) HU228296B1 (es)
ID (1) ID16643A (es)
IL (1) IL126479A (es)
IS (1) IS2159B (es)
MY (1) MY126305A (es)
NO (1) NO321954B1 (es)
NZ (1) NZ332156A (es)
PE (1) PE63998A1 (es)
PL (1) PL187294B1 (es)
PT (1) PT904098E (es)
RS (1) RS49566B (es)
SA (1) SA97180104B1 (es)
SK (1) SK281969B6 (es)
TR (1) TR199802102T2 (es)
UA (1) UA55409C2 (es)
WO (1) WO1997039763A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2250763C2 (ru) * 1999-03-03 2005-04-27 Эли Лилли Энд Компани Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
KR101536781B1 (ko) * 2006-07-26 2015-07-14 산도즈 아게 카스포펀진 제형
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
WO2009002481A1 (en) * 2007-06-26 2008-12-31 Merck & Co., Inc. Lyophilized anti-fungal composition
US8048853B2 (en) 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
US20100256074A1 (en) * 2008-06-25 2010-10-07 Chaim Eidelman Processes for preparing high purity aza cyclohexapeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102367267B (zh) * 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367269B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
CN102488887B (zh) * 2011-01-31 2014-06-18 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的药用组合物及其制备方法和用途
CN102614493B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂卡泊芬净的液体药用组合物
CN102488888B (zh) * 2011-01-31 2014-07-30 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途
CN102166186A (zh) * 2011-04-18 2011-08-31 深圳市健元医药科技有限公司 一种更加稳定的氮杂环己肽类制剂
CN102488889B (zh) * 2011-09-26 2014-01-22 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN102488886B (zh) * 2011-09-26 2014-03-26 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103212059A (zh) * 2012-01-18 2013-07-24 江苏恒瑞医药股份有限公司 含有抗真菌药物和乳酸盐缓冲液的组合物
KR102061486B1 (ko) * 2012-03-19 2020-01-03 시다라 세라퓨틱스, 인코포레이티드 에키노칸딘 계열의 화합물에 대한 투여 용법
WO2014177483A1 (en) * 2013-05-02 2014-11-06 Dsm Sinochem Pharmaceuticals Netherlands B.V. Method for isolating caspofungin
EP3058958B1 (en) 2015-02-23 2018-09-19 Selectchemie AG Anidulafungin composition
CN109154603A (zh) 2016-03-16 2019-01-04 奇达拉治疗公司 用于治疗真菌感染的给药方案
WO2019014333A1 (en) 2017-07-12 2019-01-17 Cidara Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
CN109721641B (zh) * 2017-10-31 2021-08-03 鲁南制药集团股份有限公司 一种卡泊芬净的合成方法
CN113801202A (zh) * 2020-06-15 2021-12-17 杭州中美华东制药有限公司 一种醋酸卡泊芬净杂质g的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
WO1989011297A1 (en) * 1988-05-27 1989-11-30 Centocor, Inc. Freeze-dried formulation for antibody products
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid preparations of gamma interferon

Also Published As

Publication number Publication date
EP0904098A1 (en) 1999-03-31
NO984860D0 (no) 1998-10-16
JP3258672B2 (ja) 2002-02-18
JPH11509555A (ja) 1999-08-24
YU45098A (sh) 1999-07-28
DE69722615D1 (de) 2003-07-10
HRP970201B1 (en) 2002-06-30
HU228296B1 (en) 2013-03-28
TR199802102T2 (xx) 1999-01-18
HRP970201A2 (en) 1998-08-31
CY2374B1 (en) 2004-06-04
ES2198569T3 (es) 2004-02-01
EP0904098B1 (en) 2003-06-04
BG102857A (en) 1999-09-30
PL187294B1 (pl) 2004-06-30
DZ2205A1 (fr) 2002-12-03
CO4940486A1 (es) 2000-07-24
EA001386B1 (ru) 2001-02-26
HUP9901586A2 (hu) 1999-08-30
NO984860L (no) 1998-12-18
IL126479A0 (en) 1999-08-17
CZ334798A3 (cs) 1999-06-16
NZ332156A (en) 2000-04-28
DE69722615T2 (de) 2004-04-29
BR9708706A (pt) 1999-08-03
CA2251928C (en) 2003-06-17
UA55409C2 (uk) 2003-04-15
AU2731197A (en) 1997-11-12
BR9708706B1 (pt) 2013-08-06
HUP9901586A3 (en) 2002-05-28
PT904098E (pt) 2003-09-30
AU706250B2 (en) 1999-06-10
ATE241999T1 (de) 2003-06-15
BR9708706B8 (pt) 2019-03-06
IS2159B (is) 2006-11-15
IS4858A (is) 1998-10-02
CN1222082A (zh) 1999-07-07
EA199800938A1 (ru) 1999-04-29
NO321954B1 (no) 2006-07-31
WO1997039763A1 (en) 1997-10-30
IL126479A (en) 2006-08-01
PL329442A1 (en) 1999-03-29
ID16643A (id) 1997-10-23
SK144898A3 (en) 1999-05-07
MY126305A (en) 2006-09-29
CN1132624C (zh) 2003-12-31
DK0904098T3 (da) 2003-09-15
RS49566B (sr) 2007-04-10
SK281969B6 (sk) 2001-09-11
HK1020873A1 (en) 2000-05-26
CA2251928A1 (en) 1997-10-30
EE9800345A (et) 1999-04-15
EE04265B1 (et) 2004-04-15
CZ289361B6 (cs) 2002-01-16
BRPI9708706C8 (pt) 2021-01-05
SA97180104B1 (ar) 2006-02-08
PE63998A1 (es) 1998-10-30
BG64272B1 (bg) 2004-08-31

Similar Documents

Publication Publication Date Title
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
SE8804629D0 (sv) New therapeutically active compounds
ES2094906T3 (es) Composiciones para la administracion topica de agentes farmaceuticamente activos.
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
DE60024491D1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
GEP20033079B (en) Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency
TW427906B (en) Antifungal compositions
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
UY26459A1 (es) 3,4-dihidroquinazolinas 5,6-disustituidas
ATE194498T1 (de) Wasserfreies mittel auf lactulosebasis
MX9206614A (es) Derivados de ariletanolamina, proceso para su preparacion y composicion farmaceutica que los contiene
ECSP972084A (es) Composiciones que comprenden un agente antifungoso y un tampon de acetato
ATE109981T1 (de) Therapeutische mittel.
AR010343A1 (es) Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica.
SE8303012D0 (sv) Farmaceutisk komposition
JO1679B1 (en) A new, therapeutically active compound and method for preparing it
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
ES2135424T3 (es) Composicion oral a base de ibuprofeno.

Legal Events

Date Code Title Description
FG Grant, registration